Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-25 @ 4:43 PM
NCT ID:
NCT00871403
Group ID:
EG001
Title:
Pazopanib 800 mg Plus Pemetrexed 500 mg/m^2
Description:
Oral pazopanib 800 mg once daily plus intravenous (IV) pemetrexed 500 mg/ m\^2 once every 3 weeks for 4 or 6 cycles during the Combination Treatment Phase. If participants experienced no disease progression, unacceptable toxicities, or death during the Combination Treatment Phase, they continued on pazopanib 800 mg monotherapy until disease progression, unacceptable toxicities, or death.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
34
Serious Number At Risk:
61
Other Number Affected:
59
Other Number At Risk:
61
Study:
NCT00871403
Results Section:
NCT00871403
Adverse Events Module:
NCT00871403